Dose Finding Study of HP802-247 in Venous Leg Ulcers

Exclusion Criteria

• •Women who are pregnant or lactating
• •Therapy with another investigational agent within thirty (30) days of Screening, or during the study.
• •A target ulcer of non-venous etiologies.
• •Refusal of or inability to tolerate compression therapy.
• •Therapy of the target ulcer with tissue-engineered cell-based skin equivalents within 30 days preceding the Screening Visit.
• •Therapy of the target ulcer with topical growth factors within 1 week preceding the Screening Visit.